---
title: "BTIG Reaffirms Their Buy Rating on Lightspeed POS Inc (LSPD)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294403022.md"
description: "BTIG analyst Andrew Harte reaffirmed a Buy rating on Lightspeed POS Inc (LSPD) with a $12.00 price target. This follows a Buy from RBC Capital and contrasts with Truist Financial's Hold rating. Harte, who covers the Technology sector, has a 32.48% success rate on recommendations."
datetime: "2026-07-30T18:25:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294403022.md)
  - [en](https://longbridge.com/en/news/294403022.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294403022.md)
generator: "portal-rs"
---

# BTIG Reaffirms Their Buy Rating on Lightspeed POS Inc (LSPD)

In a report released today, Andrew Harte from BTIG maintained a Buy rating on Lightspeed POS Inc, with a price target of $12.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Harte covers the Technology sector, focusing on stocks such as Lightspeed POS Inc, Strategy, and Block. According to TipRanks, Harte has an average return of -1.0% and a 32.48% success rate on recommended stocks. 

In addition to BTIG, Lightspeed POS Inc also received a Buy from RBC Capital’s Daniel Perlin in a report issued on July 26. However, on July 24, Truist Financial maintained a Hold rating on Lightspeed POS Inc (TSX: LSPD).

### Related Stocks

- [LSPD.US](https://longbridge.com/en/quote/LSPD.US.md)
- [SQ.US](https://longbridge.com/en/quote/SQ.US.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [TFC.US](https://longbridge.com/en/quote/TFC.US.md)
- [XYZ.US](https://longbridge.com/en/quote/XYZ.US.md)

## Related News & Research

- [TD Cowen Reaffirms Their Hold Rating on Lightspeed POS Inc (LSPD)](https://longbridge.com/en/news/294523118.md)
- [Lightspeed POS Inc (LSPD) Receives a Buy from CIBC](https://longbridge.com/en/news/293783055.md)
- [Piper Sandler Reaffirms Their Buy Rating on Akebia Therapeutics (AKBA)](https://longbridge.com/en/news/296105482.md)
- [Halozyme Buy Rating Reiterated as VYVGART Hytrulo Data Support Royalty Growth; $115 Price Target Unchanged](https://longbridge.com/en/news/296135927.md)
- [BTIG Reaffirms Their Hold Rating on Genco Shipping (GNK)](https://longbridge.com/en/news/296325107.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**